Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hall Ashley
Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Hall Ashley
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Coll Crespo Blas
Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Coll Crespo Blas
Structure Therapeutics | 8-K: Current report
Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Russell Angus C.
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Russell Angus C.
Structure Therapeutics | 8-K: Current report
Structure Therapeutics | 10-Q: Q2 2024 Earnings Report
Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
Structure Therapeutics | 8-K: Current report
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WELCH DANIEL G
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director TETLOW SHARON
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DOBMEIER ERIC
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Waldstreicher Joanne
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LOVE TED W
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Stevens Raymond C
Structure Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner FMR LLC
Structure Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Stevens Raymond C
Structure Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data
No Data